AGL

$87.791.34%1.16

Nachbörslich: 87.790.00 0.00%

Agilon Health Inc (AGL)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$86.63

Offen:

$86.20

24-Stunden-Volumen:

329,712

Relatives Volumen:

1.58

Marktkapitalisierung:

$1.47B

Einnahmen:

$5.82B

Nettoeinkommen (Verlust:

-$373.54M

KGV:

EPS:

-$22.55

Netto-Cashflow:

-$87.01M

1W Leistung:

-3.15%

1M Leistung:

+4.34%

6M Leistung:

+196.79%

1Y Leistung:

+333.37%

1-Tages-Spanne:

$85.27$91.11

1-Wochen-Bereich:

$82.24$94.20

52-Wochen-Spanne:

$7.48$133.04

Agilon Health Inc Aktie (AGL) Unternehmensprofil

Firmenname

Agilon Health Inc

Sektor

Healthcare

Branche

Medical Care Facilities

Telefon

562-256-3800

Adresse

440 POLARIS PARKWAY, WESTERVILLE, USA

Mitarbeiter

856

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

SEC

AGL-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Agilon Health Inc Aktie (AGL) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-15	Hochstufung	Bernstein	Mkt Perform → Outperform
2026-08-11	Hochstufung	Citigroup	Sell → Neutral
2026-07-23	Herabstufung	Citigroup	Neutral → Sell
2026-05-26	Hochstufung	Barclays	Underweight → Equal Weight
2026-05-07	Hochstufung	Deutsche Bank	Hold → Buy
2026-05-07	Hochstufung	Jefferies	Hold → Buy
2026-05-04	Herabstufung	JP Morgan	Neutral → Underweight
2025-08-20	Herabstufung	Bernstein	Outperform → Mkt Perform
2025-08-06	Herabstufung	Citigroup	Buy → Neutral
2025-04-25	Hochstufung	Citigroup	Neutral → Buy
2025-04-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2025-01-10	Hochstufung	Citigroup	Sell → Neutral
2025-01-10	Eingeleitet	Needham	Hold
2024-12-16	Eingeleitet	Macquarie	Neutral
2024-12-11	Eingeleitet	Bernstein	Mkt Perform
2024-11-11	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2024-11-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-10-30	Herabstufung	Citigroup	Neutral → Sell
2024-10-02	Herabstufung	BofA Securities	Buy → Underperform
2024-05-30	Eingeleitet	Robert W. Baird	Neutral
2024-04-22	Eingeleitet	Citigroup	Neutral
2024-03-06	Eingeleitet	Barclays	Underweight
2024-02-26	Herabstufung	Jefferies	Buy → Hold
2024-02-26	Herabstufung	TD Cowen	Outperform → Market Perform
2024-01-08	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-01-08	Herabstufung	Stifel	Buy → Hold
2024-01-08	Herabstufung	Wolfe Research	Outperform → Peer Perform
2024-01-05	Herabstufung	JP Morgan	Overweight → Neutral
2024-01-05	Herabstufung	Truist	Buy → Hold
2023-12-11	Herabstufung	Goldman	Buy → Neutral
2023-12-06	Eingeleitet	JMP Securities	Mkt Outperform
2023-11-21	Herabstufung	Deutsche Bank	Buy → Hold
2023-10-20	Eingeleitet	The Benchmark Company	Buy
2023-06-13	Eingeleitet	Evercore ISI	In-line
2022-12-09	Eingeleitet	Stifel	Buy
2022-09-14	Eingeleitet	RBC Capital Mkts	Outperform
2022-09-12	Eingeleitet	Goldman	Buy
2022-09-07	Resumed	Truist	Buy
2022-06-24	Eingeleitet	BTIG Research	Neutral
2022-03-30	Eingeleitet	Guggenheim	Buy
2021-10-20	Eingeleitet	Jefferies	Buy
2021-09-27	Eingeleitet	SVB Leerink	Outperform
2021-09-10	Eingeleitet	Cowen	Outperform
2021-05-11	Eingeleitet	William Blair	Outperform
2021-05-10	Eingeleitet	BofA Securities	Buy
2021-05-10	Eingeleitet	Deutsche Bank	Buy
2021-05-10	Eingeleitet	Goldman	Buy
2021-05-10	Eingeleitet	JP Morgan	Overweight
2021-05-10	Eingeleitet	Truist	Buy
2021-05-10	Eingeleitet	Wells Fargo	Overweight
2021-05-10	Eingeleitet	Wolfe Research	Outperform

Finanzdaten der Agilon Health Inc-Aktie (AGL)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	5,932.58	6,060.53	4,316.36	2,708.21	1,833.56
Operating expenses USD (M)	6,395.81	6,352.66	4,548.50	2,828.64	2,227.51
Operating income USD (M)	-463.24	-292.13	-232.13	-120.43	-393.95
Income before tax USD (M)	-404.10	-248.83	-194.46	-105.69	-404.60
Income tax expense USD (M)	1.25	1.45	0.79	1.64	0.89
Net income USD (M)	-391.35	-260.10	-262.80	-106.86	-406.79
Basic weighted shares shares (M)	413.97	410.97	408.92	408.15	-
Diluted weighted shares shares (M)	413.97	410.97	408.92	408.15	-

Agilon Health Inc-Aktie (AGL) Insiderhandel

Shaker BenjaminMar 02 '26
Chief Markets Officer
Transaktion
Buy
Kosten
$0.6
#Aktien
500,000
Wert ($)
301,050
#Aktien Gesamt
1,367,674
Wulf John WilliamNov 12 '25
Director
Transaktion
Buy
Kosten
$0.63
#Aktien
81,000
Wert ($)
50,941
#Aktien Gesamt
365,857

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Shaker Benjamin	Chief Markets Officer	Mar 02 '26	Buy	$0.6	500,000	301,050	1,367,674
Wulf John William	Director	Nov 12 '25	Buy	$0.63	81,000	50,941	365,857

Agilon Health Inc Aktie (AGL) Neueste Nachrichten

Oct 31, 2026

agilon health stock: Third-quarter results set for November 4 - ad-hoc-news.de

Oct 31, 2026

Oct 19, 2026

A Look at Agilon Health Inc (AGL) After 4.4% Gain -- GF Value $9 - GuruFocus

Oct 19, 2026

Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know - Yahoo Finance

Oct 19, 2026

Oct 16, 2026

Agilon Health (AGL) Short Interest & Short Float | Updated Oct 2026 $AGL - MarketBeat

Oct 16, 2026

Agilon Health (AGL) Earnings Date and Reports 2026 $AGL - MarketBeat

Oct 16, 2026

Oct 12, 2026

Is It Too Late to Buy Agilon Health Inc (AGL) After 3.8% Rally? GF Value Says Undervalued - GuruFocus

Oct 12, 2026

Oct 11, 2026

Why Is agilon health (NYSE:AGL) Extending Value-Based Care? - Kalkine Media

Oct 11, 2026

Oct 08, 2026

Why Did agilon health (AGL) Move Today? - Yahoo Finance

Oct 08, 2026

Oct 07, 2026

Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Oct 07, 2026

Oct 05, 2026

A 4:30 p.m. call will cover agilon health's third-quarter results on Nov. 4. - Stock Titan

Oct 05, 2026

agilon health Sets Date to Report Third Quarter 2026 Financial Results - Business Wire

Oct 05, 2026

Sep 30, 2026

Agilon Health Adds Jackson Clinic to Senior Health Connect ACO - Yahoo Finance

Sep 30, 2026

agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO - Business Wire

Sep 30, 2026

Sep 26, 2026